Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2026-02-21 @ 12:55 PM
Study NCT ID:
NCT06430905
Status:
TERMINATED
Last Update Posted:
2025-11-18
First Post:
2024-05-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART
Sponsor:
Hookipa Biotech GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-07-18
Completion Date Type:
ACTUAL
First Submit Date:
2024-05-17
First Submit QC Date:
None
Study First Post Date:
2024-05-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-14
Last Update Post Date:
2025-11-18
Last Update Post Date Type:
ESTIMATED